Seeking Alpha

petethepanzer

petethepanzer
Send Message
View as an RSS Feed
View petethepanzer's Comments BY TICKER:
Latest  |  Highest rated
  • Agenus: Even After Rally; Shares Still Have Upside [View article]
    if the drug QS-21 is derived from the soap bark tree then how can it be mass produced for all these vaccines...they will run out of trees wont they.
    Jul 25, 2015. 05:54 AM | Likes Like |Link to Comment
  • Agenus: Even After Rally; Shares Still Have Upside [View article]
    QS-21 Stimulon is a substance, extracted from the bark of Quillaja saponaria, an evergreen tree native to warm temperate central Chile. QS-21 Stimulon is purified from a crude extract using Agenus’ proprietary process.

    http://bit.ly/1ItLl9b

    ...so when does the Agenus malaria trial with QS-21 begin
    Jul 25, 2015. 04:30 AM | Likes Like |Link to Comment
  • Agenus: Even After Rally; Shares Still Have Upside [View article]
    are you saying switch Agenus to GSK.
    Jul 24, 2015. 10:22 AM | Likes Like |Link to Comment
  • Agenus: Even After Rally; Shares Still Have Upside [View article]
    Bret its interesting but lots of companies have antibody based drugs.

    Sevion is developing cow antibodies with extra long CDR3 for various targets...

    http://bit.ly/1I9UAF8
    Jul 21, 2015. 01:21 AM | Likes Like |Link to Comment
  • Update: RXi Pharmaceuticals Conference Presentation [View article]
    RXi platform seems pretty sketchy...at least Alnylam is validated with data.
    Jul 20, 2015. 04:00 AM | Likes Like |Link to Comment
  • Juno Therapeutics: The Future Of CAR-T Innovation [View article]
    i think 10x upside is the usual expected return...50-100 billion mcap ie. Gilead with HepC
    Jun 29, 2015. 11:51 PM | Likes Like |Link to Comment
  • Juno Therapeutics: The Future Of CAR-T Innovation [View article]
    thanks for the summary Juan you realy know your stuff
    Jun 29, 2015. 11:15 PM | Likes Like |Link to Comment
  • Juno Therapeutics: The Future Of CAR-T Innovation [View article]
    Kite is still an option here.
    Jun 29, 2015. 11:14 PM | Likes Like |Link to Comment
  • Juno Therapeutics: The Future Of CAR-T Innovation [View article]
    Kite is like identical to Juno for its lead drug.
    Jun 23, 2015. 10:32 PM | Likes Like |Link to Comment
  • Juno Therapeutics: The Future Of CAR-T Innovation [View article]
    how does this one compare to competitor Kite pharma.
    Jun 22, 2015. 01:40 AM | Likes Like |Link to Comment
  • Agenus: Even After Rally; Shares Still Have Upside [View article]
    http://seekingalpha.co...
    Jun 22, 2015. 01:39 AM | Likes Like |Link to Comment
  • Agenus: Even After Rally; Shares Still Have Upside [View article]
    an interesting article Bret:

    http://read.bi/1IjKTEI
    Jun 16, 2015. 09:08 PM | 1 Like Like |Link to Comment
  • Agenus: Even After Rally; Shares Still Have Upside [View article]
    Neostem also has a lysate vaccine in development NBS20.

    http://bit.ly/1cyOaHg
    Jun 4, 2015. 01:46 AM | 1 Like Like |Link to Comment
  • Advanced Cell Technology Is Severely Undervalued [View article]
    the potential is there...slow process though.
    Jun 2, 2015. 07:48 PM | Likes Like |Link to Comment
  • Checking In On OXiGENE After The Q1 Update [View article]
    well basically its a trade for you and nothing else.

    technology is accelerating beyond Oxigene and its simple drug.
    May 11, 2015. 01:32 PM | Likes Like |Link to Comment
COMMENTS STATS
1,077 Comments
252 Likes